Your account is not claimed yet. You can sign up with ORCID to claim your account.

Fuyuki F Inagaki (Fuyuki Inagaki)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 10

Top Venues

Cancers

Cancer science

Vaccines

ACS pharmacology & translational science

National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute

United States

Special volunteer :: Molecular Imaging Program

Publications

Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy. Cancer immunology research 10 (11) (2022)
Fuyuki F Inagaki, Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin. Pharmaceutics 14 (10) (2022)
Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts. Molecular cancer therapeutics (2022)
Fuyuki F Inagaki, Daiki Fujimura, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Takuya Kato, Peter L Choyke, Hisataka Kobayashi
Diagnostic imaging in near-infrared photoimmunotherapy using a commercially available camera for indocyanine green. Cancer science 112 (3) (2021)
Takuya Kato, Ryuhei Okada, Yuto Goto, Aki Furusawa, Fuyuki F Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto, Dagane Daar, Baris Turkbey, Peter L Choyke, Hideo Takakura, Osamu Inanami, Mikako Ogawa, Hisataka Kobayashi
Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy. ACS pharmacology & translational science 4 (5) (2021)
Ryuhei Okada, Aki Furusawa, Fuyuki F Inagaki, Hiroaki Wakiyama, Takuya Kato, Shuhei Okuyama, Hideyuki Furumoto, Hiroshi Fukushima, Peter L Choyke, Hisataka Kobayashi
Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model. Cancer science 112 (8) (2021)
Adrian Rosenberg, Fuyuki F Inagaki, Takuya Kato, Ryuhei Okada, Hiroaki Wakiyama, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi
Wound healing after excision of subcutaneous tumors treated with near-infrared photoimmunotherapy. Cancer medicine 9 (16) (2020)
Hiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Takuya Kato, Yasuhiro Maruoka, Peter L Choyke, Hisataka Kobayashi
Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy. Cancers 12 (12) (2020)
Yasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hiroaki Wakiyama, Takuya Kato, Tadanobu Nagaya, Peter L Choyke, Hisataka Kobayashi
Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors. Cancers 12 (9) (2020)
Yasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Daiki Fujimura, Hiroaki Wakiyama, Takuya Kato, Tadanobu Nagaya, Peter L Choyke, Hisataka Kobayashi
Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models. Vaccines 8 (3) (2020)

Fuyuki F Inagaki.css-eqlu8i{font-size:small;padding-left:4px;} (Fuyuki Inagaki)

Publication Activity (10 Years)

Top Topics

Top Venues

Fuyuki F Inagaki (Fuyuki Inagaki)